Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2000

View Archived Issues

Novartis and Noven enter marketing agreement for transdermal HRT

Company Profile: Naeja

Neurochem seeks U.K. approval to begin Fibrillex phase II/III trial

FDA grants fast track designation for RSR-13

First clinical trial begins for novel HDL therapy

Structural Bioinformatics reports small-molecule PTP1B inhibitors

FDA advises removal of phenylpropanolamine-containing products

Fujisawa continuing zenarestat development in Japan

NeoRx suspends STR trials

Cambridge Drug Discovery signs drug screening agreements with Avidex and RiboTargets

Cubist and Emisphere collaborate on oral delivery of daptomycin

Partnership formed for INOmax distribution in Japan

Novel antitumor compounds act by inhibiting VEGF receptor binding and function

Synthetic MMP inhibitor from Roche has promising antitumor/antiangiogenic activity

NCI-EORTC-AACR news: WP-769, a new oral doxorubicin analogue with an improved biological profile

Gelatinase-selective MMP inhibitor with potential clinical utility in cancer designed at Abbott

Structurally novel antitumor, antimetastatic and antiangiogenic agent with oral efficacy

Synthesis and preclinical evaluation of unique series of antitumor agents reported in Amsterdam

Trimetazidine analogue exerts significant hepatoprotective effects in I/R injury model in rats

First clinical results for UR-9825 discussed at Mycology meeting

Selective cGMP-PDE inhibitors synthesized at Nippon Soda

Novel series of anticoagulants patented by Kissei research team

Metalloproteinase inhibitors described by DuPont as particularly useful for arthritic conditions

Sankyo's new blood glucose-lowering agents described in recent patent

DuPont prepares aryl sulfonyl-based factor Xa inhibitors

Research at Neurogen leads to identification of new B2 receptor modulators

Synthesis and use of new NK3 receptor ligands presented by Neurogen

Shionogi patents several series of gelatinase A inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...